Sustainable Pharmaceutical Packaging Market

Sustainable Pharmaceutical Packaging Market by Raw Material (Plastics, Paper & paperboard, Glass, Metal), Product Type, Process (Recyclable, Reusable, and Biodegradable), Packaging Type(Primary Packaging), and Region - Global Forecast to 2027

Report Code: PK 8572 Feb, 2023, by marketsandmarkets.com

The global sustainable pharmaceutical packaging market was valued at USD 71.6 billion in 2022 and is projected to reach USD 146.3 billion by 2027, growing at a cagr 15.4% from 2022 to 2027. The global market is growing due to the to stringent laws and regulations levied by governments and governing bodies, as well as a shift in consumer preferences towards recyclable and eco-friendly packaging materials.

Attractive Opportunities in Sustainable Pharmaceutical Packaging Market

Sustainable Pharmaceutical Packaging Market

Note:e-estimated,p-projected.

Source: Expert Interviews, Secondary Sources, and MarketsandMarkets Analysis

To know about the assumptions considered for the study, Request for Free Sample Report

Sustainable Pharmaceutical Packaging Market Dynamics

Driver:  Consumer preference towards recyclable and eco-friendly  materials

In recent years, there has been a shift in consumer preference toward more sustainable and eco-friendly materials in the packaging industry. This trend is driven by concerns about environmental pollution and the depletion of natural resources, as well as a growing awareness of the impacts of packaging waste on the planet. Consumers are increasingly looking for packaging made from recycled materials, such as paper, cardboard, and plastic. They are also interested in biodegradable and compostable options.

Restraint: Increase in packaging cost

Sustainability policies aimed at reducing waste and increasing recycling can lead to an increase in overall packaging costs. This is because sustainable packaging materials, such as biodegradable plastics or recycled materials, are often more expensive than traditional materials. The cost of packaging design, testing, and certification to meet sustainability standards can also add to the overall cost. Implementing recycling and recovery systems for used packaging materials can also be costly. These increased costs can be passed on to consumers through higher prices for products packaged in sustainable materials.

Opportunity: Growing demand  for primary pharmaceutical packaging.

Primary pharmaceutical packaging products such as plastic bottles, glass bottles, prefilled syringes, prefilled inhalers, medication tubes, and blister packaging, among others, come in direct contact with the medicine or drug. There is a surge in demand for sustainability in primary pharmaceutical packaging due to increasing consumer awareness of environmental issues, government regulations, and industry initiatives on environmentally friendly packaging. Industry initiatives have also played a role in promoting sustainable practices in primary pharmaceutical packaging.

Challenge: Fluctuation in prices of raw material

Fluctuations in raw material prices can have a significant impact on the sustainable pharmaceutical packaging industry. Sustainability in packaging often requires using alternative materials that are less common, more complex, or more expensive than traditional options. These materials are often more sensitive to price fluctuations.The cost of producing sustainable packaging increases when raw material prices increase, which can make it less competitive with traditional packaging options. This can make it difficult for sustainable packaging manufacturers to remain profitable and make sustainable packaging more expensive for consumers. This can cause a decrease in the demand for sustainable packaging and could lead to a slowdown in the growth of the industry.

Plastics segment amongst other raw material projected to grow at a highest CAGR from 2022 to 2027, in terms of volume

Plastics can be easily formed, possess high quality, are cost-effective, and provide excellent barrier properties and freedom of design. Plastic molded containers provide superior resistance to breakage and offer safety to consumers. The use of recyclable plastics in the sustainable pharmaceutical packaging industry is becoming increasingly important as companies and consumers become more aware of the impact of packaging materials. Recyclable plastics, such as PET and HDPE, can be used to create packaging that is not only environmentally friendly but also cost-effective and safe for the storage and transportation of pharmaceutical products

Biodegradable  segment projected to grow at highest cagr from 2022 to 2027, in terms of value

The use of biodegradable packaging in the pharmaceutical industry has the potential to reduce the environmental impact of packaging materials and conserve resources. Biodegradable plastics can be composed of bioplastics manufactured from renewable raw materials. There are usually two forms of biodegradable plastic, injection molded and solid. The solid forms are generally used for food containers, leaf collection bags, and water bottles. Such plastics do not decompose unless disposed of properly, meaning that biodegradable plastics must be treated to compost.

Asia Pacific is projected to grow the fastest in the sustainable pharmaceutical packaging market during the forecast period.

The Asia Pacific region has emerged as the fastest growing market for sustainable pharmaceutical packaging. This is due to the increasing focus on sustainability and environmental protection, coupled with the rapid growth of the pharmaceutical industry in the region. The pharmaceutical industry in Asia Pacific is growing rapidly due to the large population and increasing healthcare spending, and this has increased the demand for sustainable packaging solutions. Companies in the region are investing heavily in research and development to create new and innovative sustainable packaging solutions to meet the growing demand from consumers and healthcare providers. Additionally, governments in the region are implementing policies and regulations to promote sustainable packaging and reduce environmental impact, further driving the growth of the market.

Sustainable Pharmaceutical Packaging Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Sustainable Pharmaceutical Packaging Market Industry Players

The key players in the sustaianble pharmaceutical packaging market include Schott AG (Germany), Amcor PLC (Switzerland), AptarGroup,Inc (US), West Pharmaceutical Services, Inc. (US), Berry Global (US), Gerresheimer AG (Germany), Catalent,Inc (US), and WestRock (US). The pharmaceutical packaging market report analyzes the key growth strategies, such as new product launches, investments & expansions, joint ventures, agreements, partnerships, and mergers & acquisitions adopted by the leading market players between 2019 and 2022.

Sustainable Pharmaceutical Packaging Market Report Scope

Report Metric

Details

Years considered for the study

2020–2027

Base year considered

 2021

Forecast period

2022–2027

Units considered

Volume (Kiloton) and Value (USD)

Segments

Raw Material, Product Type, Packaging Type,  Process and Region

Regions

North America, Asia Pacific, Europe, Middle East & Africa, and  South America

Companies

Schott AG (Germany), Amcor PLC (Switzerland), AptarGroup,Inc (US), West Pharmaceutical Services, Inc. (US), Berry Global (US), Gerresheimer AG (Germany), Catalent,Inc (US), and WestRock (US) 
25 major players covered.

This research report categorizes the sustaianble pharmaceutical packaging market based on raw material, types, drug delivery modes, and region.

By Material:
  • Plastics
  • Paper & paperboard
  • Glass
  • Metal
  • Others
By Packaging Type:
  • Primary Packaging
  • Secondary Packaging
By Product Type
  • Plastic bottles
  • Blister
  • Labels & accessories
  • Caps & closures
  • Pre-filled syringes
  • Medical specialty bags
  • Temp controlled packaging
  • Pouches & strip packs
  • Pre-filled inhalers
  • Vials
  • Ampoules
  • Medication tubes
  • Jars & Canisters
  • Cartriges
  • Others
By Process:
By Region:
  • North America
  • Aisa Pacific
  • Europe
  • Middle East & Africa
  • South America

The pharmaceutical packaging market has been further analyzed based on key countries in each of these regions.

Recent Developments

  • In September 2022, Aptar Pharma launched an innovative dispensing solution that is mono-material and fully recyclable when paired with a PE or PET bottle. It is suitable for a range of viscosities, customizable with two dosage options and two neck size options, and is available in a variety of colors with its unique, three-part design.
  • In September 2022, Berry Global Group, Inc. announced a collaboration with Mars Inc. to launch its popular pantry-sized treats in polyethylene terephthalate (PET) jars that have been optimized by including 15% recycled plastic content, i.e., post-consumer resin (PCR).
  •  In November 2022, Aptar Pharma announced its collaboration with TFF Pharmaceuticals. This collaboration is aimed at developing and testing the administration of dry powder vaccines utilizing TFF Pharmaceutical’s Thin Film Freezing technology and Aptar Pharma’s proprietary intranasal Unidose (UDS) powder nasal spray system.
  • In June 2022, WestRock Company announced a partnership with Recipe Unlimited to introduce a line of recyclable paperboard packaging, with the goal of keeping 31 million plastic bottles out of Canada's landfills annually.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 34)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
    1.3 STUDY SCOPE 
           1.3.1 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SEGMENTATION
           1.3.2 REGIONAL SCOPE
    1.4 YEARS CONSIDERED 
    1.5 CURRENCY CONSIDERED 
    1.6 UNIT CONSIDERED 
    1.7 STAKEHOLDERS 
    1.8 INCLUSIONS AND EXCLUSIONS 
          TABLE 1 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: INCLUSIONS AND EXCLUSIONS
    1.9 SUMMARY OF CHANGES 
    1.10 LIMITATIONS 
 
2 RESEARCH METHODOLOGY (Page No. - 39)
    2.1 RESEARCH DATA 
          FIGURE 1 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Key primary insights
                                FIGURE 2 LIST OF STAKEHOLDERS AND BREAKDOWN OF PRIMARY INTERVIEWS
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
          FIGURE 4 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
          FIGURE 5 MARKET SIZE ESTIMATION: SUPPLY SIDE
    2.3 DATA TRIANGULATION 
          FIGURE 6 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION
    2.4 RESEARCH ASSUMPTIONS 
    2.5 RESEARCH LIMITATIONS 
    2.6 GROWTH FORECAST 
 
3 EXECUTIVE SUMMARY (Page No. - 47)
    FIGURE 7 PLASTICS TO HOLD LARGEST SHARE IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET
    FIGURE 8 PRIMARY PACKAGING TO BE FASTER-GROWING SEGMENT OF SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET
    FIGURE 9 BIODEGRADABLE SEGMENT TO GROW AT HIGHEST CAGR FROM 2022 TO 2027
    FIGURE 10 ASIA PACIFIC TO BE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD
 
4 PREMIUM INSIGHTS (Page No. - 50)
    4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET 
          FIGURE 11 EMERGING ECONOMIES TO OFFER ATTRACTIVE OPPORTUNITIES IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET
    4.2 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL 
          FIGURE 12 PLASTICS SEGMENT TO REGISTER HIGHEST CAGR FROM 2022 TO 2027
    4.3 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION AND RAW MATERIAL, 2021 
          FIGURE 13 NORTH AMERICA AND PLASTICS SEGMENT ACCOUNTED FOR LARGEST SHARES
    4.4 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY KEY COUNTRIES 
          FIGURE 14 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET IN INDIA TO WITNESS HIGHEST CAGR
 
5 MARKET OVERVIEW (Page No. - 53)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET
           5.2.1 DRIVERS
                    5.2.1.1 Government initiatives for sustainable packaging
                    5.2.1.2 Consumer preference toward recyclable and eco-friendly materials
                    5.2.1.3 Downsizing of packaging
                    5.2.1.4 Breakthrough in new technologies and innovations
                    5.2.1.5 High growth in generics and biopharmaceuticals markets
           5.2.2 RESTRAINTS
                    5.2.2.1 Poor infrastructure facilities for recycling
                    5.2.2.2 Lack of awareness of sustainability
                    5.2.2.3 High packaging costs
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing demand for primary pharmaceutical packaging
           5.2.4 CHALLENGES
                    5.2.4.1 Volatile raw material prices
    5.3 VALUE CHAIN ANALYSIS 
          FIGURE 16 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS
           5.3.1 RAW MATERIAL SUPPLIERS
           5.3.2 R&D OF PRODUCTS
           5.3.3 MANUFACTURERS
           5.3.4 DISTRIBUTORS
           5.3.5 END USERS
           5.3.6 POST-DISPOSAL PROCESS
                    TABLE 2 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKETING: VALUE CHAIN STAKEHOLDERS
    5.4 PORTER'S FIVE FORCES ANALYSIS 
          FIGURE 17 PORTER'S FIVE FORCES ANALYSIS OF SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET
           5.4.1 THREAT OF NEW ENTRANTS
           5.4.2 THREAT OF SUBSTITUTES
           5.4.3 BARGAINING POWER OF BUYERS
           5.4.4 BARGAINING POWER OF SUPPLIERS
           5.4.5 INTENSITY OF COMPETITIVE RIVALRY
                    TABLE 3 IMPACT OF PORTER'S FIVE FORCES ON SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET
    5.5 REGULATORY LANDSCAPE 
           5.5.1 REGULATIONS
                    5.5.1.1 Europe
                    5.5.1.2 US
                    5.5.1.3 Others
    5.6 TECHNOLOGY ANALYSIS 
           5.6.1 AUTOMATED RECYCLING
           5.6.2 EMERGENCE OF TECHNOLOGICALLY ADVANCED RAW MATERIALS
           5.6.3 NANOTECHNOLOGY
           5.6.4 PACKAGING FOR BIOLOGICS
           5.6.5 SMART PACKAGING
           5.6.6 ANTI-COUNTERFEIT PACKAGING
           5.6.7 OTHER SMART TRENDS AND TECHNOLOGIES
    5.7 PRICING ANALYSIS 
           5.7.1 AVERAGE SELLING PRICE, BY REGION
                    FIGURE 18 AVERAGE SELLING PRICE, BY REGION (USD/KG)
           5.7.2 AVERAGE SELLING PRICE, BY RAW MATERIAL
                    TABLE 4 AVERAGE SELLING PRICE, BY RAW MATERIAL (USD/KG)
           5.7.3 AVERAGE SELLING PRICE, BY COMPANY
                    TABLE 5 AVERAGE SELLING PRICE, BY COMPANY (USD/KG)
    5.8 ECOSYSTEM MAPPING 
           FIGURE 19 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING
    5.9 IMPACT OF COVID-19 ON PHARMACEUTICAL PACKAGING MARKET 
           5.9.1 IMPACT ON HEALTHCARE INDUSTRY
    5.10 IMPACT OF RECESSION ON PHARMACEUTICAL PACKAGING MARKET 
    5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 
           FIGURE 20 SMART PACKAGING, IOT, AND NANOTECHNOLOGY TO DRIVE MARKET
    5.12 PATENT ANALYSIS 
           5.12.1 INTRODUCTION
           5.12.2 METHODOLOGY
           5.12.3 DOCUMENT TYPE
                     FIGURE 21 GRANTED PATENTS, LIMITED PATENTS, AND PATENT APPLICATIONS
           5.12.4 PUBLICATION TRENDS DURING 2011–2021
                     FIGURE 22 NUMBER OF PATENTS DURING 2011–2021
           5.12.5 INSIGHTS
           5.12.6 JURISDICTION ANALYSIS
                     FIGURE 23 TOP JURISDICTIONS
           5.12.7 TOP PATENT APPLICANTS
                     FIGURE 24 TOP 10 PATENT APPLICANTS
                     TABLE 6 LIST OF PATENTS BY SANOFI AVENTIS DEUTSCHLAND
                     TABLE 7 LIST OF PATENTS BY SCHOTT AG
                     TABLE 8 LIST OF PATENTS BY TERUMO CORP
                     TABLE 9 LIST OF PATENTS BY BECTON, DICKINSON AND COMPANY
                     TABLE 10 TOP 10 PATENT OWNERS (US) IN LAST 10 YEARS
    5.13 TRADE ANALYSIS 
    5.14 OPERATIONAL DATA 
    5.15 KEY CONFERENCES AND EVENTS IN 2022–2023 
            TABLE 11 KEY CONFERENCES AND EVENTS IN 2022–2023
    5.16 CASE STUDY ANALYSIS 
           5.16.1 OPTHALMIC SQUEEZE DISPENSER BY APTAR PHARMA TO CONTRIBUTE TO OVERALL ESG COMMITMENTS
           5.16.2 MOISTURE BARRIER TECHNOLOGY FOR BETTER DRUG DELIVERY
           5.16.3 CUSTOM TECHNOLOGY FOR BETTER BREATHING
 
6 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL (Page No. - 86)
    6.1 INTRODUCTION 
          FIGURE 25 PLASTICS TO DOMINATE SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET
          TABLE 12 BASIC PACKAGING RAW MATERIALS USED IN PHARMACEUTICAL PACKAGING
          TABLE 13 RAW MATERIAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION)
          TABLE 14 RAW MATERIAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 15 RAW MATERIAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON)
          TABLE 16 RAW MATERIAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON)
          TABLE 17 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION)
          TABLE 18 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION)
          TABLE 19 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON)
          TABLE 20 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON)
    6.2 PLASTICS 
           6.2.1 COST-EFFECTIVENESS AND EXCELLENT BARRIER PROPERTIES OF PLASTICS TO DRIVE MARKET
                    TABLE 21 PLASTICS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 22 PLASTICS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 23 PLASTICS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON)
                    TABLE 24 PLASTICS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON)
           6.2.2 HIGH-DENSITY POLYETHYLENE (HDPE)
           6.2.3 POLYPROPYLENE (PP)
           6.2.4 LOW-DENSITY POLYETHYLENE (LDPE)
           6.2.5 POLYVINYL CHLORIDE (PVC)
           6.2.6 POLYETHYLENE TEREPHTHALATE (PET)
           6.2.7 BIO-BASED PLASTICS (BBP)
           6.2.8 BIODEGRADABLE PLASTICS
    6.3 PAPER & PAPERBOARD 
           6.3.1 INNOVATIONS IN SECONDARY PACKAGING TO BOOST MARKET
                    TABLE 25 PAPER & PAPERBOARD: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 26 PAPER & PAPERBOARD: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 27 PAPER & PAPERBOARD: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON)
                    TABLE 28 PAPER & PAPERBOARD: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON)
    6.4 GLASS 
           6.4.1 EXCELLENT CHEMICAL RESISTANCE AND RECYCLABILITY OF GLASS TO PROPEL MARKET
                    TABLE 29 GLASS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 30 GLASS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 31 GLASS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON)
                    TABLE 32 GLASS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON)
                    TABLE 33 TYPES OF GLASS USED IN PACKAGING
    6.5 METAL 
           6.5.1 INCREASING USE OF ALUMINUM FOR BLISTER PACKAGING TO DRIVE MARKET
                    TABLE 34 METAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 35 METAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 36 METAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON)
                    TABLE 37 METAL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON)
    6.6 OTHER RAW MATERIALS 
          TABLE 38 OTHER RAW MATERIALS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION)
          TABLE 39 OTHER RAW MATERIALS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 40 OTHER RAW MATERIALS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (KILOTON)
          TABLE 41 OTHER RAW MATERIALS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (KILOTON)
 
7 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PRODUCT TYPE (Page No. - 106)
    7.1 INTRODUCTION 
    7.2 PLASTIC BOTTLES 
           7.2.1 EASY OPERABILITY AND SHATTER RESISTANCE OF PLASTIC BOTTLES TO SUPPORT MARKET
           7.2.2 STANDARD PLASTIC BOTTLES
           7.2.3 PLASTIC DISPENSING BOTTLES
           7.2.4 PLASTIC JARS
    7.3 LABELS & ACCESSORIES 
           7.3.1 PATIENT-DRUG COMMUNICATION COMPLIANCE TO DRIVE MARKET
           7.3.2 SELF-ADHESIVE LABELS
           7.3.3 DIE-CUT LABELS
           7.3.4 TAMPER-PROOF LABELS
           7.3.5 HOLOGRAPHIC STRIP LABELS
    7.4 CAPS & CLOSURES 
           7.4.1 PREFERENCE FOR POLYPROPYLENE AND POLYETHYLENE-BASED CAPS & CLOSURES TO FAVOR MARKET GROWTH
    7.5 MEDICAL SPECIALTY BAGS 
           7.5.1 WIDE USE OF LLDPE AND PE TO CONTRIBUTE TO MARKET GROWTH
    7.6 PREFILLED SYRINGES 
           7.6.1 HIGH DEMAND IN DEVELOPED AND EMERGING ECONOMIES TO DRIVE MARKET
    7.7 TEMPERATURE-CONTROLLED PACKAGING 
           7.7.1 INCREASING PRODUCTION OF SPECIALIZED DRUGS TO INFLUENCE MARKET GROWTH POSITIVELY
    7.8 POUCHES & STRIP PACKS 
           7.8.1 GROWING DEMAND FOR STANDUP POUCHES TO DRIVE MARKET
    7.9 AMPOULES 
           7.9.1 HIGH DEMAND FROM EMERGING ECONOMIES TO SPUR MARKET GROWTH
    7.10 VIALS 
           7.10.1 DEMAND FOR VACCINE PACKAGING TO DRIVE MARKET
    7.11 MEDICATION TUBES 
           7.11.1 GROWTH OF FLEXIBLE PACKAGING IN EMERGING ECONOMIES TO BOOST MARKET
           7.11.2 COMPOSITE TUBES
           7.11.3 ALL-PLASTIC TUBES
           7.11.4 COLLAPSIBLE METAL TUBES
    7.12 JARS & CANISTERS 
           7.12.1 INCREASING DEMAND FOR PROTECTIVE PACKAGING TO FUEL MARKET
    7.13 CARTRIDGES 
           7.13.1 BALANCED PACKAGING OFFERED BY CARTRIDGES TO DRIVE MARKET
    7.14 OTHER TYPES 
 
8 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE (Page No. - 115)
    8.1 INTRODUCTION 
          FIGURE 26 PRIMARY PACKAGING FORMAT TO BE LARGER SEGMENT
          TABLE 42 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION)
          TABLE 43 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION)
    8.2 PRIMARY PACKAGING 
           8.2.1 USE OF ALUMINUM OR GLASS TO REDUCE ENVIRONMENTAL IMPACT OF PRIMARY PACKAGING
                    TABLE 44 PRIMARY PACKAGING: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 45 PRIMARY PACKAGING: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION)
    8.3 SECONDARY PACKAGING 
           8.3.1 USE OF PLANT-BASED MATERIALS IN SECONDARY PACKAGING TO GAIN MOMENTUM
                    TABLE 46 SECONDARY PACKAGING: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 47 SECONDARY PACKAGING: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION)
 
9 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS (Page No. - 120)
    9.1 INTRODUCTION 
          FIGURE 27 RECYCLABLE PROCESS SEGMENT TO BE LARGER SEGMENT
          TABLE 48 PROCESS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION)
          TABLE 49 PROCESS: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 50 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
          TABLE 51 SUSTAINABLE PLASTIC PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
    9.2 RECYCLABLE 
           9.2.1 FOCUS OF PACKAGING COMPANIES TO IMPROVE RECYCLING INFRASTRUCTURE TO DRIVE MARKET
                    TABLE 52 RECYCLABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 53 RECYCLABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.3 REUSABLE 
           9.3.1 DURABILITY OF TERTIARY PACKAGING TO FUEL MARKET
                    TABLE 54 REUSABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION)
                    TABLE 55 REUSABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.4 BIODEGRADABLE 
           9.4.1 INNOVATION TO PLAY KEY ROLE IN BIODEGRADABLE PLASTIC PACKAGING
                    TABLE 56 BIODEGRADABLE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION)
 
10 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION (Page No. - 127)
     10.1 INTRODUCTION 
             FIGURE 28 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET IN INDIA TO REGISTER HIGHEST CAGR
             TABLE 57 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2016–2019 (USD MILLION)
             TABLE 58 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.2 NORTH AMERICA 
             10.2.1 RECESSION IMPACT
                        FIGURE 29 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
                        TABLE 59 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                        TABLE 60 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 61 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION)
                        TABLE 62 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION)
                        TABLE 63 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                        TABLE 64 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                        TABLE 65 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION)
                        TABLE 66 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION)
                        TABLE 67 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON)
                        TABLE 68 NORTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON)
             10.2.2 US
                        10.2.2.1 Environmental responsibility to drive market
                                      TABLE 69 US: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 70 US: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.2.3 CANADA
                        10.2.3.1 Government initiative to reduce overall quantity of packaging waste to boost market
                                      TABLE 71 CANADA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 72 CANADA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.2.4 MEXICO
                        10.2.4.1 Gradual economic recovery to support market
                                      TABLE 73 MEXICO: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 74 MEXICO: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
     10.3 ASIA PACIFIC 
             10.3.1 RECESSION IMPACT
                        FIGURE 30 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
                        TABLE 75 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                        TABLE 76 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 77 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION)
                        TABLE 78 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION)
                        TABLE 79 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                        TABLE 80 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                        TABLE 81 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION)
                        TABLE 82 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION)
                        TABLE 83 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON)
                        TABLE 84 ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON)
             10.3.2 CHINA
                        10.3.2.1 Increasing awareness of eco-friendly, sustainable, and renewable packaging to drive market
                                      TABLE 85 CHINA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 86 CHINA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.3.3 JAPAN
                        10.3.3.1 Increasing demand for generic drugs to propel market
                                      TABLE 87 JAPAN: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 88 JAPAN: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.3.4 SOUTH KOREA
                        10.3.4.1 Well-developed healthcare industry and presence of major pharmaceutical manufacturers to drive market
                                      TABLE 89 SOUTH KOREA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 90 SOUTH KOREA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.3.5 INDIA
                        10.3.5.1 Increasing domestic consumption and export of generic drugs to fuel market
                                      TABLE 91 INDIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 92 INDIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.3.6 AUSTRALIA
                        10.3.6.1 PBS schemes to strengthen pharmaceutical industry
                                      TABLE 93 AUSTRALIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 94 AUSTRALIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.3.7 REST OF ASIA PACIFIC
                        TABLE 95 REST OF ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                        TABLE 96 REST OF ASIA PACIFIC: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
     10.4 EUROPE 
             10.4.1 RECESSION IMPACT
                        TABLE 97 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                        TABLE 98 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 99 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION)
                        TABLE 100 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION)
                        TABLE 101 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                        TABLE 102 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                        TABLE 103 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION)
                        TABLE 104 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION)
                        TABLE 105 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON)
                        TABLE 106 EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON)
             10.4.2 GERMANY
                        10.4.2.1 Government initiatives for boosting recycling rate to drive market
                                      TABLE 107 GERMANY: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 108 GERMANY: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.4.3 FRANCE
                        10.4.3.1 High demand for generic drugs to drive market
                                      TABLE 109 FRANCE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 110 FRANCE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.4.4 ITALY
                        10.4.4.1 Growing exports of pharmaceuticals to boost market
                                      TABLE 111 ITALY: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 112 ITALY: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.4.5 UK
                        10.4.5.1 Innovations in drug manufacturing to increase demand
                                      TABLE 113 UK: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 114 UK: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.4.6 SPAIN
                        10.4.6.1 Macroeconomic factors to have positive impact on market
                                      TABLE 115 SPAIN: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 116 SPAIN: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.4.7 RUSSIA
                        10.4.7.1 Government initiatives for domestic production of pharmaceuticals to fuel market
                                      TABLE 117 RUSSIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 118 RUSSIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.4.8 REST OF EUROPE
                        TABLE 119 REST OF EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                        TABLE 120 REST OF EUROPE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
     10.5 MIDDLE EAST & AFRICA 
             10.5.1 RECESSION IMPACT
                        TABLE 121 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                        TABLE 122 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 123 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION)
                        TABLE 124 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION)
                        TABLE 125 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                        TABLE 126 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                        TABLE 127 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION)
                        TABLE 128 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION)
                        TABLE 129 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON)
                        TABLE 130 MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON)
             10.5.2 SAUDI ARABIA
                        10.5.2.1 Wider access to healthcare services to increase demand for pharmaceuticals
                                      TABLE 131 SAUDI ARABIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 132 SAUDI ARABIA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.5.3 SOUTH AFRICA
                        10.5.3.1 Gradual rise in generic drug use to fuel market
                                      TABLE 133 SOUTH AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 134 SOUTH AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.5.4 UAE
                        10.5.4.1 Increasing initiatives for domestic pharmaceutical production to drive market
                                      TABLE 135 UAE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 136 UAE: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.5.5 REST OF MIDDLE EAST & AFRICA
                        TABLE 137 REST OF MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                        TABLE 138 REST OF MIDDLE EAST & AFRICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
     10.6 SOUTH AMERICA 
             10.6.1 RECESSION IMPACT
                        TABLE 139 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2016–2019 (USD MILLION)
                        TABLE 140 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 141 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2016–2019 (USD MILLION)
                        TABLE 142 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2027 (USD MILLION)
                        TABLE 143 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                        TABLE 144 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
                        TABLE 145 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (USD MILLION)
                        TABLE 146 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (USD MILLION)
                        TABLE 147 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2016–2019 (KILOTON)
                        TABLE 148 SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2027 (KILOTON)
             10.6.2 BRAZIL
                        10.6.2.1 Free and universal healthcare services to support pharmaceutical industry
                                      TABLE 149 BRAZIL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 150 BRAZIL: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.6.3 ARGENTINA
                        10.6.3.1 Increasing awareness and development of recycling facilities to drive market
                                      TABLE 151 ARGENTINA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                                      TABLE 152 ARGENTINA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
             10.6.4 REST OF SOUTH AMERICA
                        TABLE 153 REST OF SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2016–2019 (USD MILLION)
                        TABLE 154 REST OF SOUTH AMERICA: SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, BY PROCESS, 2020–2027 (USD MILLION)
 
11 COMPETITIVE LANDSCAPE (Page No. - 180)
     11.1 OVERVIEW 
     11.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             TABLE 155 COMPANIES ADOPTED INVESTMENT & EXPANSION AND PRODUCT LAUNCH AS KEY GROWTH STRATEGIES BETWEEN 2019 AND 2022
     11.3 MARKET EVALUATION MATRIX 
             TABLE 156 MARKET EVALUATION MATRIX
     11.4 REVENUE ANALYSIS 
             TABLE 157 REVENUE OF KEY COMPANIES DURING 2019–2021
     11.5 RANKING ANALYSIS OF KEY MARKET PLAYERS, 2021 
             FIGURE 31 RANKING OF TOP 5 PLAYERS IN SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET, 2021
             11.5.1 BERRY GLOBAL INC.
             11.5.2 AMCOR PLC
             11.5.3 APTARGROUP, INC.
             11.5.4 GERRESHEIMER AG
             11.5.5 SCHOTT AG
     11.6 MARKET SHARE ANALYSIS 
             FIGURE 32 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET SHARE, BY COMPANY (2021)
             TABLE 158 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: DEGREE OF COMPETITION
     11.7 COMPANY EVALUATION MATRIX (TIER-1 PLAYERS) 
             11.7.1 STARS
             11.7.2 PERVASIVE PLAYERS
             11.7.3 EMERGING LEADERS
             11.7.4 PARTICIPANTS
                        FIGURE 33 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX FOR TIER-1 COMPANIES, 2021
     11.8 STRENGTH OF PRODUCT PORTFOLIO (TIER-1 PLAYERS) 
     11.9 BUSINESS STRATEGY EXCELLENCE (TIER-1 PLAYERS) 
     11.10 START-UP AND SME MATRIX 
             11.10.1 PROGRESSIVE COMPANIES
             11.10.2 RESPONSIVE COMPANIES
             11.10.3 STARTING BLOCKS
             11.10.4 DYNAMIC COMPANIES
                        FIGURE 34 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS AND SMES, 2021
     11.11 STRENGTH OF PRODUCT PORTFOLIO (START-UPS AND SMES) 
     11.12 BUSINESS STRATEGY EXCELLENCE (START-UPS AND SMES) 
     11.13 COMPETITIVE BENCHMARKING 
              TABLE 159 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: LIST OF COMPANIES
             11.13.1 COMPANY TYPE FOOTPRINT
                        TABLE 160 OVERALL TYPE FOOTPRINT
             11.13.2 COMPANY REGION FOOTPRINT
                        TABLE 161 OVERALL REGION FOOTPRINT
             11.13.3 COMPANY FOOTPRINT
                        TABLE 162 OVERALL COMPANY FOOTPRINT
     11.14 COMPETITIVE SITUATION AND TRENDS 
             11.14.1 PRODUCT LAUNCHES
                        TABLE 163 PHARMACEUTICAL PACKAGING MARKET: PRODUCT LAUNCHES, 2019–2022
             11.14.2 DEALS
                        TABLE 164 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: DEALS, 2019–2022
             11.14.3 OTHER DEVELOPMENTS
                        TABLE 165 SUSTAINABLE PHARMACEUTICAL PACKAGING MARKET: OTHER DEVELOPMENTS, 2019–2021
 
12 COMPANY PROFILES (Page No. - 213)
(Business Overview, Products Offered, Recent Developments, Sustainability goals, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
     12.1 KEY PLAYERS 
             12.1.1 BERRY GLOBAL INC.
                        TABLE 166 BERRY GLOBAL INC.: COMPANY OVERVIEW
                        FIGURE 35 BERRY GLOBAL INC.: COMPANY SNAPSHOT
                        TABLE 167 BERRY GLOBAL INC.: PRODUCTS OFFERED
                        TABLE 168 BERRY GLOBAL INC.: PRODUCT LAUNCHES
                        TABLE 169 BERRY GLOBAL INC.: DEALS
                        TABLE 170 BERRY GLOBAL INC.: OTHER DEVELOPMENTS
             12.1.2 GERRESHEIMER AG
                        TABLE 171 GERRESHEIMER AG: COMPANY OVERVIEW
                        FIGURE 36 GERRESHEIMER AG: COMPANY SNAPSHOT
                        TABLE 172 GERRESHEIMER AG: PRODUCTS OFFERED
                        TABLE 173 GERRESHEIMER AG: PRODUCT LAUNCHES
                        TABLE 174 GERRESHEIMER AG: DEALS
                        TABLE 175 GERRESHEIMER AG: OTHER DEVELOPMENTS
             12.1.3 AMCOR PLC
                        TABLE 176 AMCOR PLC: COMPANY OVERVIEW
                        FIGURE 37 AMCOR PLC: COMPANY SNAPSHOT
                        TABLE 177 AMCOR PLC: PRODUCTS OFFERED
                        TABLE 178 AMCOR PLC: PRODUCT LAUNCHES
                        TABLE 179 AMCOR PLC: DEALS
                        TABLE 180 AMCOR PLC: OTHER DEVELOPMENTS
             12.1.4 SCHOTT AG
                        TABLE 181 SCHOTT AG: COMPANY OVERVIEW
                        FIGURE 38 SCHOTT AG: COMPANY SNAPSHOT
                        TABLE 182 SCHOTT AG: PRODUCTS OFFERED
                        TABLE 183 SCHOTT AG: PRODUCT LAUNCHES
                        TABLE 184 SCHOTT AG: DEALS
                        TABLE 185 SCHOTT AG: OTHER DEVELOPMENTS
             12.1.5 APTARGROUP, INC.
                        TABLE 186 APTARGROUP, INC.: COMPANY OVERVIEW
                        FIGURE 39 APTARGROUP, INC.: COMPANY SNAPSHOT
                        TABLE 187 APTARGROUP, INC.: PRODUCTS OFFERED
                        TABLE 188 APTARGROUP, INC.: PRODUCT LAUNCHES
                        TABLE 189 APTARGROUP, INC.: DEALS
                        TABLE 190 APTARGROUP, INC.: OTHER DEVELOPMENTS
             12.1.6 BECTON, DICKINSON AND COMPANY
                        TABLE 191 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
                        FIGURE 40 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
                        TABLE 192 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
                        TABLE 193 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES
                        TABLE 194 BECTON, DICKINSON AND COMPANY: DEALS
             12.1.7 WESTROCK COMPANY
                        TABLE 195 WESTROCK COMPANY: COMPANY OVERVIEW
                        FIGURE 41 WESTROCK COMPANY: COMPANY SNAPSHOT
                        TABLE 196 WESTROCK COMPANY: PRODUCTS OFFERED
                        TABLE 197 WESTROCK COMPANY: DEALS
             12.1.8 NIPRO CORPORATION
                        TABLE 198 NIPRO CORPORATION: COMPANY OVERVIEW
                        FIGURE 42 NIPRO CORPORATION: COMPANY SNAPSHOT
                        TABLE 199 NIPRO CORPORATION: PRODUCTS OFFERED
                        TABLE 200 NIPRO CORPORATION: DEALS
             12.1.9 CATALENT, INC.
                        TABLE 201 CATALENT, INC.: COMPANY OVERVIEW
                        FIGURE 43 CATALENT, INC.: COMPANY SNAPSHOT
                        TABLE 202 CATALENT, INC.: PRODUCTS OFFERED
                        TABLE 203 CATALENT, INC.: DEALS
                        TABLE 204 CATALENT, INC.: OTHER DEVELOPMENTS
             12.1.10 SEALED AIR CORPORATION
                        TABLE 205 SEALED AIR CORPORATION: COMPANY OVERVIEW
                        FIGURE 44 SEALED AIR CORPORATION: COMPANY SNAPSHOT
                        TABLE 206 SEALED AIR CORPORATION: PRODUCTS OFFERED
                        TABLE 207 SEALED AIR CORPORATION: PRODUCT LAUNCHES
                        TABLE 208 SEALED AIR CORPORATION: DEALS
             12.1.11 WEST PHARMACEUTICAL SERVICES, INC.
                        TABLE 209 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW
                        FIGURE 45 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT
                        TABLE 210 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCTS OFFERED
                        TABLE 211 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCT LAUNCHES
                        TABLE 212 WEST PHARMACEUTICAL SERVICES, INC.: DEALS
                        TABLE 213 WEST PHARMACEUTICAL SERVICES, INC.: OTHER DEVELOPMENTS
     12.2 OTHER PLAYERS 
             12.2.1 ALPLA WERKE ALWIN LEHNER GMBH & CO KG
                        TABLE 214 ALPLA WERKE ALWIN LEHNER GMBH & CO KG: COMPANY OVERVIEW
             12.2.2 ARDAGH GROUP S.A.
                        TABLE 215 ARDAGH GROUP S.A.: COMPANY OVERVIEW
             12.2.3 CCL INDUSTRIES INC.
                        TABLE 216 CCL INDUSTRIES INC.: COMPANY OVERVIEW
             12.2.4 FRANK NOE EGYPT LTD.
                        TABLE 217 FRANK NOE EGYPT LTD.: COMPANY OVERVIEW
             12.2.5 GAPLAST GMBH
                        TABLE 218 GAPLAST GMBH: COMPANY OVERVIEW
             12.2.6 LONZA GROUP LTD.
                        TABLE 219 LONZA GROUP LTD.: COMPANY OVERVIEW
             12.2.7 MONDI GROUP
                        TABLE 220 MONDI GROUP: COMPANY OVERVIEW
             12.2.8 NOLATO AB
                        TABLE 221 NOLATO AB: COMPANY OVERVIEW
             12.2.9 ORIGIN PHARMA PACKAGING
                        TABLE 222 ORIGIN PHARMA PACKAGING: COMPANY OVERVIEW
             12.2.10 COMAR
                        TABLE 223 COMAR: COMPANY OVERVIEW
             12.2.11 BILCARE LIMITED
                        TABLE 224 BILCARE LIMITED: COMPANY OVERVIEW
             12.2.12 SGD PHARMA
                        TABLE 225 SGD PHARMA: COMPANY OVERVIEW
             12.2.13 SILGAN HOLDINGS INC.
                        TABLE 226 SILGAN HOLDINGS INC.: COMPANY OVERVIEW
             12.2.14 VETTER PHARMA INTERNATIONAL GMBH
                        TABLE 227 VETTER PHARMA INTERNATIONAL GMBH: COMPANY OVERVIEW
 
*Details on Business Overview, Products Offered, Recent Developments, Sustainability goals, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
 
13 APPENDIX (Page No. - 279)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 RELATED REPORTS 
     13.4 AUTHOR DETAILS 

The study involved four major activities in estimating the current market size for pharmaceutical packaging. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, the market breakdown and data triangulation methodologies were used to estimate the market size of segments and sub-segments.

Secondary Research

In the secondary research process, various secondary sources such as Factiva, Bloomberg, World Bank, Statista, Packaging Industry Associations, Trademap, Zauba, were referred to for identifying and collecting information for this study. These secondary sources included annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, regulations form agencies such as the Food & Drug Administration (FDA), World Health organization (WHO), The European Federation of Pharmaceutical Industries and Associations (EFPIA), Pharmaceuticals Export Promotion Council of India, regulatory bodies, and databases.

Primary Research

Extensive primary research has been conducted after acquiring an understanding of the sustainable  pharmaceutical packaging market scenario through secondary research The pharmaceutical packaging market comprises several stakeholders such as raw material suppliers, distributors of pharmaceutical packaging, end-users, and regulatory organizations in the supply chain. The demand side of this market consists of pharmaceutical drug manufacturers, medical drug filling contractors, hospitals, labs, research institutes, and other healthcare institutions. Several primary interviews have been conducted with market experts from both the demand- (pharmaceutical packaging manufacturers) and supply-side (end-product manufacturers, buyers, and distributors) players across six major regions, namely, North America, Western Europe, Eastern & Central Europe, Asia Pacific, Middle East & Africa, and South America.

Following is the breakdown of primary respondents

Sustainable Pharmaceutical Packaging Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the sustainable pharmaceutical packaging market. These methods were also used extensively to estimate the size of various sub-segments in the market. The research methodology used to estimate the market size includes the following:

  • The key players, raw material,  product type, process, and packaging type in the industry and markets were identified through extensive secondary research.
  • The industry’s supply chain and market size, in terms of value and volume, were determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size—using the market size estimation process explained above—the market was split into several segments and sub-segments. In order to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply of sustainable pharmaceutical packaging and their applications.

Report Objective:

  • To analyze and forecast size of thesustainable pharmaceutical packaging market in terms of value and volume.
  • To provide detailed information about the key factors (drivers, restraints, opportunities, and challenges) influencing the growth of the market
  • To analyze and forecast the market by type, by raw material, product type, process, packaging type and region.
  • To forecast the size of the market with respect to five regions: Asia Pacific, Europe, North America, South America, and the Middle East & Africa, along with their key countries
  • To strategically analyze micro markets with respect to individual trends, future prospects, and their contribution to the overall market
  • To analyze opportunities in the market for stakeholders and provide a competitive landscape for market leaders.
  • To analyze competitive developments such as mergers & acquisitions, new product developments, investments & expansions, and agreements & partnerships in the market
  • Strategically profile key players and comprehensively analyze their market shares and core competencies.

Available Customizations:

MarketsandMarkets offers customizations according to the specific needs of the companies with the given market data.

The following customization options are available for the pharmaceutical packaging market report:

Product Analysis

  • Product matrix, which provides a detailed comparison of the product portfolio of each company

Regional Analysis

  • A further breakdown of the pharmaceutical packaging market, by segments

Company Information

  • Detailed analysis and profiling of additional market players (up to five)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
PK 8572
Published ON
Feb, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Sustainable Pharmaceutical Packaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback